Edesa Biotech is trading at $5.36 (-5.30%) following a weak start to the July 24 trading session, extending a period of significant price fluctuations.
- The move comes during a volatile stretch for the stock, which previously fell 5.80% on July 22 and 11.82% on July 20.
- No company-specific announcements, earnings updates, or guidance changes have been identified to explain the recent downward pressure.
- With broader markets currently mixed, the decline does not appear to be tied to general index-wide weakness.